Search clinical trials for: AD-209 placebo
Total 55854 results
-
Brigham and Women's HospitalNational Human Genome Research Institute (NHGRI)CompletedAlzheimer DiseaseUnited States
-
University of ValenciaMinistry of Science and InnovationNot yet recruiting
-
Wake Forest University Health SciencesNot yet recruitingOsteoarthritisUnited States
-
Translational Research Center for Medical Innovation...Daiichi Sankyo Co., Ltd.Completed
-
Hookipa Biotech GmbHRecruitingHPV-Related Squamous Cell CarcinomaUnited States, Spain, Netherlands
-
Mayo ClinicRecruiting
-
Guangdong Provincial Hospital of Traditional Chinese...CompletedPsoriasis | Drug Effect | Drug Toxicity | Mesenchymal Stromal CellsChina
-
The First Affiliated Hospital with Nanjing Medical...UnknownMyocardial Infarction
-
Region SkaneCompleted
-
Tonix Pharmaceuticals, Inc.CompletedTension-Type HeadacheUnited States
-
University Hospital, Basel, SwitzerlandNovartis; Swiss National Science FoundationCompletedCoronavirus Infection | Diabetes Mellitus, Type 2Switzerland
-
University of PennsylvaniaCompleted
-
Alexza Pharmaceuticals, Inc.CompletedParkinson's DiseaseNetherlands
-
Suzhou Yabao Pharmaceutical R&D Co., Ltd.Completed
-
Elusys TherapeuticsCompleted
-
Merck Sharp & Dohme LLCHIV Vaccine Trials NetworkTerminatedHIV Infections | AIDS
-
TWi Biotechnology, Inc.CompletedType 2 Diabetes MellitusUnited States, Taiwan
-
Duke UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)TerminatedCigarette Smoking | Nicotine WithdrawalUnited States
-
Northwestern UniversityCompleted
-
University of BernCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)CompletedDepression | HIV Infections | HIVUnited States
-
Aarhus University HospitalNot yet recruiting
-
University of Medicine and Pharmacy at Ho Chi Minh...National Institute on Aging (NIA); University of California, Davis; National...RecruitingAlzheimer DiseaseVietnam
-
University of OklahomaNational Institute on Drug Abuse (NIDA); Oklahoma State UniversityCompletedNicotine Dependence | Cigarette Smoking | Nicotine WithdrawalUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedPsoriasisGermany, Israel, Poland, Spain
-
Capital Medical UniversityRecruitingDiffuse Intrinsic Pontine Glioma | Adverse Drug Event | Oncolytic VirusChina
-
Capital Medical UniversityRecruitingDiffuse Intrinsic Pontine Glioma | Adverse Drug Event | Oncolytic VirusChina
-
Wageningen UniversityCompletedEating BehaviorNetherlands
-
Hebrew SeniorLifeCompletedDementia | Infection, BacterialUnited States
-
SoseiNovartisCompletedCOPDBulgaria, Poland, Hungary, Romania
-
Annexon, Inc.Nucleus Network LtdCompletedSafety and Tolerability in Healthy VolunteersAustralia
-
Memorial Sloan Kettering Cancer CenterHookipa Biotech GmbH; NaverisRecruitingHPV16+ Squamous Cell CarcinomaUnited States
-
Glyscend, Inc.Recruiting
-
TakedaRecruiting
-
ICM Co. Ltd.Enrolling by invitationOsteoarthritis, KneeAustralia
-
ILIAS Biologics Inc.Completed
-
Priscilla Hsue, MDUniversity of California, Los Angeles; University of UtahWithdrawnHIV Infection | Inflammation | Cardiovascular DiseaseUnited States
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Jeil Pharmaceutical Co., Ltd.Completed
-
RXi Pharmaceuticals, Corp.CompletedHypertrophic ScarUnited States, Honduras
-
RXi Pharmaceuticals, Corp.CompletedKeloidUnited States, Dominican Republic
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Belgium, Canada, Netherlands, Germany
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States
-
Akron Molecules AGCompleted
-
RXi Pharmaceuticals, Corp.CompletedCicatrix | Scar PreventionUnited States
-
Sangamo TherapeuticsCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic PolyneuropathyUnited States, Mexico
-
Sangamo TherapeuticsCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic PolyneuropathyUnited States
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedActive Plaque PsoriasisUnited States, Germany, Israel